CPHI [CHINA PHARMAS,] S-3: Zhilin Li President and Chief Executive Officer 2nd

[Zhilin Li President and Chief Executive Officer 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (Name,dress,luding zipde, and Telephone Number,luding areade, ofent for Service) With apy to: Charles Law, Esq. King & Wood 125 S. Market Street, Suite 1175,] [cphs3ex41122209.htm 2 EX-4.1] [December 28, 2009 China Pharmas, Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China RE: China Pharmas, Form S-3 Registration Statement (File No. 333- ) Dear Sir or Madam: Based upon the foregoing, and subject to thesumptions stated herein, we are of the opinion that:] [HEN B ARNETT & M AXWELL , P.C. A Professionalrporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 www.hbmcpas.com Registered with the Publicmpany Accounting Oversight Board To the Board of Directors and the Shareholders China Pharmas, an independent registered public accounting firm, we herebynsent to theorporation by reference in this Registration Statement on Form S-3]

By | 2016-02-07T23:59:12+00:00 December 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]

By | 2016-03-03T21:22:38+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q:

[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]

By | 2016-03-03T21:24:52+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[China Pharmas, TABLE OFNTENTS Part I Financial Information 1 Item 1. Financial Statements 1ndensednsolidated Balance Sheets ofSeptember 30, 2009 and December 31, 2008 (Unaudited) 1ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months EndedSeptember 30, 2009 and 2008 (Unaudited)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended September 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended September 30, 2009 filed with the Frank Waung Chief Financial Officer cph10qex322093009.htm 5 EX-32.2]

By | 2016-02-08T00:00:10+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: China Pharmas, TABLE OFNTENTS Part I Financial Information

[China Pharmas, TABLE OFNTENTS Part I Financial Information 1 Item 1. Financial Statements 1ndensednsolidated Balance Sheets ofSeptember 30, 2009 and December 31, 2008 (Unaudited) 1ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months EndedSeptember 30, 2009 and 2008 (Unaudited)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended September 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended September 30, 2009 filed with the Frank Waung Chief Financial Officer cph10qex322093009.htm 5 EX-32.2]

By | 2016-02-08T00:01:01+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[China Pharma Holdings, Inc. Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex. China Pharma expects to begin trading on NYSE Amex]

By | 2016-03-03T21:30:45+00:00 October 1st, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: China Pharma Holdings, Inc. Announces Approval for NYSE

[China Pharma Holdings, Inc. Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex. China Pharma expects to begin trading on NYSE Amex]

By | 2016-03-03T21:32:23+00:00 October 1st, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: China Pharmas, Announces Approval for NYSE Amex Listing

[China Pharmas, Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharmas, ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and marketsecialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex.]

By | 2016-02-08T00:04:43+00:00 October 1st, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar